Potentiation of the anti-tumour effects of Photofrin®- based photodynamic therapy by localized treatment with G-CSF

British Journal of Cancer

Volumn 82, Issue 8, 2000, Pages 1485-1491

  Golab J ^a   Wilczynski G ^b   Zagozdzon R ^a,c   Stoklosa, T ^a   Dabrowska A ^a   Rybczynska J ^c   Wasik M ^c   Machaj, E ^d   Oldak, T ^b   Kozar, K ^a   Kaminski R ^a   Giermasz, A ^a   Czajka, A ^a   Lasek, W ^a   Feleszko, W ^a   Jakobisiak M ^a  

^a MEDICAL UNIVERSITY OF WARSAW   (Poland)

^b Department of Pathology ^*  (Poland)

^c MEDICAL UNIVERSITY OF WARSAW   (Poland)

^d INSTITUTE OF ONCOLOGY   (Poland)

Author keywords

G CSF; Neutrophils; Photodynamic therapy; Photofrin

Indexed keywords

GRANULOCYTE COLONY STIMULATING FACTOR; PHOTOFRIN; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; BONE MARROW; CANCER SURVIVAL; COLON CANCER; CONTROLLED STUDY; LEWIS CARCINOMA; MYELOPOIESIS; NEUTROPHIL; NONHUMAN; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; SPLEEN; TUMOR IMMUNITY;

EID: 0034069751     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1054/bjoc.1999.1078     Document Type: Article

References (30)

1. Ahmad N, Feyes DK, Agarwal R and Mkhtar H (1998) Photodynamic therapy results in induction of waf1/cip1/p21 leading to cell cycle arrest and apoptosis. Proc Natl Acad Sci USA 95: 6977-6982
2. Albert MI, Pearce SFA, Francisco LM, Sauter B, Roy P, Silverstein RL and Bhardwaj N (1998) Immature dendritic cells phagocytose apoptotic cells via αvβ5 and CD36, and cross-present antigens to cytotoxic T lymphocytes. J Exp Med 188: 1359-1368
3. Ben-Hur E, Heldman E, Crane SW and Rosenthal I (1988) Release of clotting factors from photosensitized endothelial cells: a possible trigger for blood vessel occlusion by photodynamic therapy. FEBS Lett 236: 105-108
4. de Vree WJA, Essers MC, de Bruijn HS, Star WM, Koster JF and Sluiter W (1996a) Evidence for an important role of neutrophils in the efficacy of photodynamic therapy in vivo. Cancer Res 56: 2908-2911
5. de Vree WJA, Fontijne-Dorsman ANRD, Koster JF and Suiter W (1996b) Photodynamic treatment of human endothelial cells promotes the adherence of neutrophils in vitro. Br J Cancer 73: 2908-2911
6. Dougherly TJ, Gomer CJ, Henderson BW, Jori G, Kessel D, Korbelik M, Moan J and Peng Q (1998) Photodynamic therapy. J Natl Acad Sci 90: 889-905
7. Faddy C, Reisser D and Marin F (1990) Non-activated neutrophils kill syngeneic colon tumour cells by the release of low molecular weight factor. Immunobiology 181: 1-12
8. Fingar VH, Wieman TJ, Wiehle SA and Cerrito PB (1992) The role of microvascular damage in photodynamic therapy: the effect of treatment on vessel constriction, permeability, and leukocyte adhesion. Cancer Res 52: 4914-4921
9. Fingar VH, Wieman TJ and Haydon PS (1997) The effects of thrombocytopenia on vessel stasis and macromolecular leakage after photodynamic therapy using photofrin. Photochem Photobiol 66: 4914-4921
10. Foster TH, Primavera MC, Marder VJ, Hilf R and Sporn LA (1991) Photosensitized release of von Willebrand factor from cultured human endothelial cells. Cancer Res 51: 3261-3266
11. Gola̧b J, Stoklosa T, Zagoźdźon R, Kaca A, Giermasz A, Pojda Z, Machaj E, Da̧browska A, Feleszko W, Lasek, W, Iwan-Osiecka A and Jakóbisiak M (1998a). G-CSF prevents the suppression of bone marrow hematopoiesis induced by IL-12 and augments its antitumour activity in a melanoma model in mice. Ann Oncol 9: 63-69
12. Gola̧b J, Stoklosa T, Zagoźdźon R, Kaca A, Kulchitska, LA, Feleszko W, Kawiak J, Hoser G, Glowacka E, Da̧browska A, Giermasz A, Lasek W and Jakóbisiak M (1998b). Granulocyte-macrophage colony-stimulating factor potentiates antitumour activity of interleukin-12 in melanoma model in mice. Tumour Biol 19: 77-87
13. Granville DJ, Levy JG and Hunt DWC (1997) Photodynamic therapy induces caspase-3 activation in HL-60 cells. Cell Death Differ 4: 623-628
14. Henderson, BW and Dougherty, TJ (1992) How does photodynamic therapy work? Photochem Photobiol 55: 623-628
15. Hunt DWC, Sorrenti RA, Renke ME, Waterfield E and Levy JG (1995) Accelerated myelopoietic recovery in irradiated mice treated with photofrin. Int J Immunopharmacol 17: 33-39
16. Hunt DWC, Jiang H and Levy JG (1998) Photofrin® increasess murine spleen cell transferrin receptor expression and responsiveness to recombinant myeloid and erythroid growth factors. Immunopharmacology 37: 267-278
17. Kashtan H, Haddad R, Yossiphov Y, Bar-On S and Skornick Y (1996) Photodynamic therapy of colorectal cancer using a new light source: from in vitro studies to a patient treatment. Dis Colon Rectum 39: 379-383
18. Korbelik M (1996) Induction of tumour immunity hy photodynamic therapy. J Clin Laser Med Surg 14: 329-334
19. Korbelik M and Dougherty GJ (1999) Photodynamic therapy-mediated immune response against mouse tumours. Cancer Res 59: 1941-1946
20. Korbelik M, Krosl G, Krosl J and Dougherty GJ (1996) Role of host lymphoid populations in the response of mouse emt6 tumour to pnotodynamic therapy. Cancer Res 56: 5647-5652
21. Korbelik M, Naraparaju VR and Yamamoto N (1997) Macrophage-directed immunotherapy as adjuvant to photodynamic therapy of cancer. Br J Cancer 75: 202-207
22. Krosl G, Korbelik M and Dougherty GJ (1995) Induction of immune cell infiltration into murine SSCVII tumour by photofrin-based photodynamic therapy. Br J Cancer 71: 549-555
23. Krosl G, Korbelik M, Krosl J and Dougherty GJ (1996) Potentiation of photodynamic therapy-elicited antitumour response by localized treatment with granulocyte-macrophage colony-stimulating factor. Cancer Res 56: 3281-3286
24. Nseyo U, Whalen RK, Duncan MR, Berman B and Lundahl SL (1990) Urinary cytokines following photodynamic therapy for bladder cancer. A preliminary report. Urology 36: 167-171
25. Ochsner M (1997) Photophysical and photobiological processes in the photodynamic therapy of tumours. J Photochem Photobiol 39: 1-18
26. Pass HI (1993) Photodynamic therapy in oncology: mechanisms and clinical use. J Natl Cancer Inst 85: 443-456
27. Reynolds T (1997) Photodynamic therapy expands its horizons. J Natl Cancer Inst 89: 112-114
28. Stoppacciaro A, Melani C, Parenza M, Mastracchio A, Bassi C, Baroni C, Parmiani G and Colombo MP (1993) Regression of an established tumour genetically modified to release granulocyte colony-stimulating factor requires granulocyte-T cell cooperation and T cell-produced interferon γ. J Exp Med 178: 151-161
29. Welte K, Gabrilove J, Bronchud MH and Platzer E (1996) Filgrastim (r-methuG-CSF): the first 10 years. Blood 88: 1907-1929
30. Zilocchi C, Stoppacciaro A, Chiodoni C, Parenza M, Terrazzini, N. and Colombo, MP (1998) Interferon γ-independent rejection of interleukin 12-transduced carcinoma cells requires CD4+ T cells and granulocyte/macrophage colony-stimulating factor. J Exp Med 188: 133-143